Linden Thomas Advisory Services’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
28,038
+4,455
| +19% | +$389K | 0.27% | 108 |
|
|
2025
Q1 | $1.61M | Buy |
23,583
+1,811
| +8% | +$124K | 0.21% | 179 |
|
|
2024
Q4 | $1.69M | Buy |
21,772
+473
| +2% | +$36.8K | 0.21% | 166 |
|
|
2024
Q3 | $1.43M | Buy |
21,299
+1,205
| +6% | +$80.8K | 0.2% | 206 |
|
|
2024
Q2 | $2.28M | Buy |
20,094
+5,844
| +41% | +$663K | 0.35% | 66 |
|
|
2024
Q1 | $1.98M | Buy |
14,250
+874
| +7% | +$121K | 0.32% | 97 |
|
|
2023
Q4 | $1.66M | Buy |
13,376
+330
| +3% | +$41K | 0.31% | 114 |
|
|
2023
Q3 | $1.22M | Sell |
13,046
-3,643
| -22% | -$340K | 0.27% | 168 |
|
|
2023
Q2 | $2.14M | Buy |
16,689
+202
| +1% | +$26K | 0.48% | 39 |
|
|
2023
Q1 | $1.92M | Buy |
16,487
+566
| +4% | +$65.8K | 0.48% | 46 |
|
|
2022
Q4 | $1.8M | Buy |
+15,921
| New | +$1.8M | 0.51% | 46 |
|